Myths and Fake Messages About Human Papillomavirus (HPV) Vaccination: Answers from the ESGO Prevention Committee

Overview

Journal Int J Gynecol Cancer

Specialties Gynecology & Obstetrics
Oncology

Date 2022 Jul 12

PMID 35820716

Authors

Nadja Taumberger

Elmar A Joura

Marc Arbyn

Maria Kyrgiou

Jalid Sehouli

Murat Gultekin

Affiliations

Soon will be listed here.

Citing Articles

Cultural barriers and facilitators of the parents for human papillomavirus (HPV) vaccination uptake by their daughters: A systematic review.

Salleh N, Abdullah K, Chow H J Pediatr (Rio J). 2024; 101(2):133-149.

PMID: 39510130 PMC: 11889688. DOI: 10.1016/j.jped.2024.07.012.

Stakeholders' Perceptions on the Implementation of the HPV Vaccine School-Entry Requirement in Puerto Rico during the COVID-19 Pandemic.

Vazquez-Otero C, Medina-Laabes D, Perez-Guzman D, Diaz-Miranda O, Mercado-Andino A, Escabi-Wojna E Vaccines (Basel). 2024; 12(7).

PMID: 39066398 PMC: 11281630. DOI: 10.3390/vaccines12070760.

Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study.

Dalla Valle D, Benoni R, Soriolo N, Battistella C, Moretti F, Gonella L Vaccine X. 2024; 19:100511.

PMID: 39040889 PMC: 11260860. DOI: 10.1016/j.jvacx.2024.100511.

Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect.

Han L, Zhang B Infect Agent Cancer. 2023; 18(1):66.

PMID: 37898754 PMC: 10613367. DOI: 10.1186/s13027-023-00547-2.

Reproductive and Obstetric Outcomes after Fertility-Sparing Treatments for Cervical Cancer: Current Approach and Future Directions.

Terzic M, Makhadiyeva D, Bila J, Andjic M, Dotlic J, Aimagambetova G J Clin Med. 2023; 12(7).

PMID: 37048696 PMC: 10095321. DOI: 10.3390/jcm12072614.

References

Meites E, Kempe A, Markowitz L . Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016; 65(49):1405-1408. DOI: 10.15585/mmwr.mm6549a5. View

Geier D, Geier M . Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database. Immunol Res. 2016; 65(1):46-54. PMC: 5406441. DOI: 10.1007/s12026-016-8815-9. View

Bednarczyk R, Davis R, Ault K, Orenstein W, Omer S . Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics. 2012; 130(5):798-805. DOI: 10.1542/peds.2012-1516. View

Coles V, Patel A, Allen F, Keeping S, Carroll S . The association of human papillomavirus vaccination with sexual behaviours and human papillomavirus knowledge: a systematic review. Int J STD AIDS. 2014; 26(11):777-88. DOI: 10.1177/0956462414554629. View

Sonawane K, Zhu Y, Montealegre J, Lairson D, Bauer C, McGee L . Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey. Lancet Public Health. 2020; 5(9):e484-e492. PMC: 7484349. DOI: 10.1016/S2468-2667(20)30139-0. View

Kasting M, Shapiro G, Rosberger Z, Kahn J, Zimet G . Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research. Hum Vaccin Immunother. 2016; 12(6):1435-50. PMC: 4964724. DOI: 10.1080/21645515.2016.1141158. View

Vorsters A, Arbyn M, Baay M, Bosch X, de Sanjose S, Hanley S . Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Res. 2017; 4:45-53. PMC: 7268103. DOI: 10.1016/j.pvr.2017.07.001. View

Segal Y, Dahan S, Calabro M, Kanduc D, Shoenfeld Y . HPV and systemic lupus erythematosus: a mosaic of potential crossreactions. Immunol Res. 2017; 65(2):564-571. DOI: 10.1007/s12026-016-8890-y. View

Gruber N, Shoenfeld Y . A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis. Curr Opin Obstet Gynecol. 2015; 27(4):265-70. DOI: 10.1097/GCO.0000000000000183. View

10.

Drolet M, Benard E, Perez N, Brisson M . Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019; 394(10197):497-509. PMC: 7316527. DOI: 10.1016/S0140-6736(19)30298-3. View

11.

Beachler D, Jenkins G, Safaeian M, Kreimer A, Wentzensen N . Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis. J Infect Dis. 2015; 213(9):1444-54. PMC: 4813740. DOI: 10.1093/infdis/jiv753. View

12.

Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J . Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. MMWR Morb Mortal Wkly Rep. 2014; 63(29):620-4. PMC: 5779422. View

13.

Little D, Ward H . Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice. J Investig Med High Impact Case Rep. 2015; 2(4):2324709614556129. PMC: 4528880. DOI: 10.1177/2324709614556129. View

14.

Kjaer S, Dehlendorff C, Belmonte F, Baandrup L . Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer. J Natl Cancer Inst. 2021; 113(10):1329-1335. PMC: 8486335. DOI: 10.1093/jnci/djab080. View

15.

Frisch M, Besson A, Clemmensen K, Valentiner-Branth P, Molbak K, Hviid A . Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism. Int J Epidemiol. 2018; 47(2):634-641. DOI: 10.1093/ije/dyx273. View

16.

Bednarczyk R . Addressing HPV vaccine myths: practical information for healthcare providers. Hum Vaccin Immunother. 2019; 15(7-8):1628-1638. PMC: 6746482. DOI: 10.1080/21645515.2019.1565267. View

17.

Moreira Jr E, Block S, Ferris D, Giuliano A, Iversen O, Joura E . Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials. Pediatrics. 2016; 138(2). DOI: 10.1542/peds.2015-4387. View

18.

Smith L, Kaufman J, Strumpf E, Levesque L . Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study. CMAJ. 2014; 187(2):E74-E81. PMC: 4312170. DOI: 10.1503/cmaj.140900. View

19.

Hviid A, Thiesson E . Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort. JAMA Netw Open. 2021; 4(8):e2120391. PMC: 8391101. DOI: 10.1001/jamanetworkopen.2021.20391. View

20.

Joura E, Giuliano A, Iversen O, Bouchard C, Mao C, Mehlsen J . A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015; 372(8):711-23. DOI: 10.1056/NEJMoa1405044. View